| Mr Adam Westenhofer, OTR/L, CHT | |
|
122 S Gold Ave Ste A, Deming, NM 88030-3755 | |
| (575) 283-0200 | |
| (575) 283-0238 |
| Full Name | Mr Adam Westenhofer |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapy |
| Experience | 11 Years |
| Location | 122 S Gold Ave Ste A, Deming, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679995625 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 3164 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vida Therapy Group, Llc | 7810377579 | 3 |
News Archive
Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients.
The La Jolla Institute for Allergy & Immunology will develop San Diego's first Center for RNAi screening - a breakthrough genomics technology that will further enhance San Diego's reputation as a national research leader and provide the local biomedical community ready access to the Nobel-Prize winning technology.
In advance of the 41st Union World Conference, the Global Alliance for TB Drug Development (TB Alliance) today announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients. This novel three-drug combination shows promise to treat both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.
A telemedicine initiative in Vanderbilt's Department of Hearing and Speech Sciences is working to make follow-up hearing tests for newborns more accessible in rural areas of Tennessee, while teaching young pediatric audiology and pediatric speech language pathology students to treat patients remotely.
› Verified 2 days ago
| Provider Name | Vida Therapy Group, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1619621000 PECOS PAC ID: 7810377579 Enrollment ID: O20220712001814 |
News Archive
Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients.
The La Jolla Institute for Allergy & Immunology will develop San Diego's first Center for RNAi screening - a breakthrough genomics technology that will further enhance San Diego's reputation as a national research leader and provide the local biomedical community ready access to the Nobel-Prize winning technology.
In advance of the 41st Union World Conference, the Global Alliance for TB Drug Development (TB Alliance) today announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients. This novel three-drug combination shows promise to treat both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.
A telemedicine initiative in Vanderbilt's Department of Hearing and Speech Sciences is working to make follow-up hearing tests for newborns more accessible in rural areas of Tennessee, while teaching young pediatric audiology and pediatric speech language pathology students to treat patients remotely.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Adam Westenhofer, OTR/L, CHT 122 S Gold Ave Ste A, Deming, NM 88030-3755 Ph: (575) 283-0200 | Mr Adam Westenhofer, OTR/L, CHT 122 S Gold Ave Ste A, Deming, NM 88030-3755 Ph: (575) 283-0200 |
News Archive
Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients.
The La Jolla Institute for Allergy & Immunology will develop San Diego's first Center for RNAi screening - a breakthrough genomics technology that will further enhance San Diego's reputation as a national research leader and provide the local biomedical community ready access to the Nobel-Prize winning technology.
In advance of the 41st Union World Conference, the Global Alliance for TB Drug Development (TB Alliance) today announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients. This novel three-drug combination shows promise to treat both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.
A telemedicine initiative in Vanderbilt's Department of Hearing and Speech Sciences is working to make follow-up hearing tests for newborns more accessible in rural areas of Tennessee, while teaching young pediatric audiology and pediatric speech language pathology students to treat patients remotely.
› Verified 2 days ago
Evangeline R Randall, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1321 E Poplar St, Deming, NM 88030 Phone: 575-546-5951 Fax: 575-546-5994 | |
Vida Therapy Group, Llc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 122 S Gold Ave Ste A, Deming, NM 88030 Phone: 575-283-0200 Fax: 575-283-0238 | |
Mrs. Virginia Nicholls Aldea, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 N Pearl St, Deming, NM 88030 Phone: 575-544-4663 Fax: 575-544-4665 |